{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T15:14:27Z","timestamp":1778944467066,"version":"3.51.4"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003625","name":"Korea Ministry of Health and Welfare","doi-asserted-by":"publisher","award":["RS-2025-02263992"],"award-info":[{"award-number":["RS-2025-02263992"]}],"id":[{"id":"10.13039\/501100003625","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Heart Journal"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.ahj.2025.07.005","type":"journal-article","created":{"date-parts":[[2025,7,5]],"date-time":"2025-07-05T10:54:18Z","timestamp":1751712858000},"page":"258-267","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["The impact of body mass index on antiplatelet monotherapy strategy for secondary prevention after percutaneous coronary intervention: A substudy of the HOST-EXAM trial"],"prefix":"10.1016","volume":"290","author":[{"given":"Minju","family":"Han","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeehoon","family":"Kang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bitna","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Doyeon","family":"Hwang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Han-Mo","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kyung Woo","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ki-Bum","family":"Won","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jung-Kyu","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bon-Kwon","family":"Koo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eun-Seok","family":"Shin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hyo-Soo","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"10293","key":"10.1016\/j.ahj.2025.07.005_bib0001","doi-asserted-by":"crossref","first-page":"2487","DOI":"10.1016\/S0140-6736(21)01063-1","article-title":"Aspirin versus clopidogrel for chronic maintenance monotherapy after percutaneous coronary intervention (HOST-EXAM): an investigator-initiated, prospective, randomised, open-label, multicentre trial","volume":"397","author":"Koo","year":"2021","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.ahj.2025.07.005_bib0002","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1161\/CIRCULATIONAHA.122.062770","article-title":"Aspirin versus clopidogrel for long-term maintenance monotherapy after percutaneous coronary intervention: the HOST-EXAM extended study","volume":"147","author":"Kang","year":"2023","journal-title":"Circulation"},{"issue":"9","key":"10.1016\/j.ahj.2025.07.005_bib0003","doi-asserted-by":"crossref","first-page":"e9","DOI":"10.1161\/CIR.0000000000001168","article-title":"AHA\/ACC\/ACCP\/ASPC\/NLA\/PCNA Guideline for the management of patients with chronic coronary disease: a report of the American Heart Association\/American College of Cardiology Joint Committee on Clinical Practice Guidelines","volume":"148","author":"Virani","year":"2023","journal-title":"Circulation"},{"issue":"36","key":"10.1016\/j.ahj.2025.07.005_bib0004","doi-asserted-by":"crossref","first-page":"3415","DOI":"10.1093\/eurheartj\/ehae177","article-title":"2024 ESC guidelines for the management of chronic coronary syndromes","volume":"45","author":"Vrints","year":"2024","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ahj.2025.07.005_bib0005","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/3407306","article-title":"The impact of obesity on the cardiovascular system","volume":"2018","author":"Csige","year":"2018","journal-title":"J Diabetes Res"},{"issue":"17","key":"10.1016\/j.ahj.2025.07.005_bib0006","doi-asserted-by":"crossref","first-page":"2218","DOI":"10.1093\/eurjpc\/zwac187","article-title":"Obesity and cardiovascular disease: mechanistic insights and management strategies. A joint position paper by the World Heart Federation and World Obesity Federation","volume":"29","author":"Lopez-Jimenez","year":"2022","journal-title":"Eur J Prev Cardiol"},{"issue":"4","key":"10.1016\/j.ahj.2025.07.005_bib0007","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/S0735-1097(01)01802-2","article-title":"The impact of obesity on the short-term and long-term outcomes after percutaneous coronary intervention: the obesity paradox?","volume":"39","author":"Gruberg","year":"2002","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"10.1016\/j.ahj.2025.07.005_bib0008","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.121.023667","article-title":"Body mass index and association with cardiovascular outcomes in patients with stable coronary heart disease: a stability substudy","volume":"11","author":"Held","year":"2022","journal-title":"J Am Heart Assoc"},{"issue":"4","key":"10.1016\/j.ahj.2025.07.005_bib0009","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1001\/jamacardio.2018.0022","article-title":"Association of body mass index with lifetime risk of cardiovascular disease and compression of morbidity","volume":"3","author":"Khan","year":"2018","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.ahj.2025.07.005_bib0010","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.atherosclerosis.2018.08.047","article-title":"Association between body mass index and clinical outcomes after new-generation drug-eluting stent implantation: korean multi-center registry data","volume":"277","author":"Kim","year":"2018","journal-title":"Atherosclerosis"},{"issue":"\u2013126","key":"10.1016\/j.ahj.2025.07.005_bib0011","article-title":"Aspirin antiplatelet effects are associated with body weight","volume":"125","author":"Mourikis","year":"2020","journal-title":"Vascul Pharmacol"},{"issue":"4","key":"10.1016\/j.ahj.2025.07.005_bib0012","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1097\/FJC.0000000000000288","article-title":"Body mass index and platelet reactivity during dual antiplatelet therapy with Clopidogrel or Ticagrelor","volume":"66","author":"Nardin","year":"2015","journal-title":"J Cardiovasc Pharmacol"},{"issue":"6","key":"10.1016\/j.ahj.2025.07.005_bib0013","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1007\/s40262-017-0611-8","article-title":"Obesity and altered aspirin pharmacology","volume":"57","author":"Norgard","year":"2018","journal-title":"Clin Pharmacokinet"},{"issue":"1","key":"10.1016\/j.ahj.2025.07.005_bib0014","doi-asserted-by":"crossref","first-page":"3","DOI":"10.2174\/1872312811666170301110349","article-title":"Obesity and inflammation and altered clopidogrel pharmacokinetics and pharmacodynamics","volume":"11","author":"Norgard","year":"2017","journal-title":"Drug Metab Lett"},{"issue":"2","key":"10.1016\/j.ahj.2025.07.005_bib0015","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1253\/circj.CJ-22-0344","article-title":"Body mass index and major adverse events during chronic antiplatelet monotherapy after percutaneous coronary intervention with drug-eluting stents - results from the HOST-EXAM trial","volume":"87","author":"Won","year":"2023","journal-title":"Circ J"},{"issue":"4","key":"10.1016\/j.ahj.2025.07.005_bib0016","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.amjcard.2014.11.022","article-title":"Relation of body mass index to bleeding during percutaneous coronary interventions","volume":"115","author":"Ndrepepa","year":"2015","journal-title":"Am J Cardiol"},{"issue":"4","key":"10.1016\/j.ahj.2025.07.005_bib0017","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0124399","article-title":"Impact of body mass index on in-hospital complications in patients undergoing percutaneous coronary intervention in a Japanese real-world multicenter registry","volume":"10","author":"Numasawa","year":"2015","journal-title":"PLoS One"},{"issue":"11","key":"10.1016\/j.ahj.2025.07.005_bib0018","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1016\/j.amjcard.2009.07.015","article-title":"Relation of body mass index to high on-treatment platelet reactivity and of failed clopidogrel dose adjustment according to platelet reactivity monitoring in patients undergoing percutaneous coronary intervention","volume":"104","author":"Bonello-Palot","year":"2009","journal-title":"Am J Cardiol"},{"issue":"4","key":"10.1016\/j.ahj.2025.07.005_bib0019","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1080\/09537104.2019.1667495","article-title":"Weight as an assay-independent predictor of poor response to enteric aspirin in cardiovascular patients","volume":"31","author":"McCall","year":"2020","journal-title":"Platelets"},{"issue":"10145","key":"10.1016\/j.ahj.2025.07.005_bib0020","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/S0140-6736(18)31133-4","article-title":"Effects of aspirin on risks of vascular events and cancer according to bodyweight and dose: analysis of individual patient data from randomised trials","volume":"392","author":"Rothwell","year":"2018","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.ahj.2025.07.005_bib0021","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1007\/s10557-022-07325-z","article-title":"Being overweight or obese is associated with an increased platelet reactivity despite dual antiplatelet therapy with aspirin and clopidogrel","volume":"37","author":"Puccini","year":"2023","journal-title":"Cardiovasc Drugs Ther"},{"issue":"24","key":"10.1016\/j.ahj.2025.07.005_bib0022","doi-asserted-by":"crossref","first-page":"2428","DOI":"10.1001\/jama.2019.8146","article-title":"Effect of P2Y12 inhibitor monotherapy vs dual antiplatelet therapy on cardiovascular events in patients undergoing percutaneous coronary intervention: the SMART-CHOICE randomized clinical trial","volume":"321","author":"Hahn","year":"2019","journal-title":"JAMA"},{"issue":"23","key":"10.1016\/j.ahj.2025.07.005_bib0023","doi-asserted-by":"crossref","first-page":"2407","DOI":"10.1001\/jama.2020.7580","article-title":"Effect of Ticagrelor monotherapy vs Ticagrelor with Aspirin on major bleeding and cardiovascular events in patients with acute coronary syndrome: the TICO randomized clinical Trial","volume":"323","author":"Kim","year":"2020","journal-title":"JAMA"},{"issue":"4","key":"10.1016\/j.ahj.2025.07.005_bib0024","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1001\/jamacardio.2021.5244","article-title":"Comparison of Clopidogrel monotherapy after 1 to 2 months of dual antiplatelet therapy with 12 months of dual antiplatelet therapy in patients with acute coronary syndrome: the STOPDAPT-2 ACS randomized clinical trial","volume":"7","author":"Watanabe","year":"2022","journal-title":"JAMA Cardiol"},{"issue":"9403","key":"10.1016\/j.ahj.2025.07.005_bib0025","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0140-6736(03)15268-3","article-title":"Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies","volume":"363","year":"2004","journal-title":"Lancet."},{"issue":"1","key":"10.1016\/j.ahj.2025.07.005_bib0026","doi-asserted-by":"crossref","first-page":"66","DOI":"10.47102\/annals-acadmedsg.V38N1p66","article-title":"Deurenberg-Yap M. Rationale for redefining obesity in Asians","volume":"38","author":"Low","year":"2009","journal-title":"Ann Acad Med Singap"},{"key":"10.1016\/j.ahj.2025.07.005_bib0027","unstructured":"Pacific WHOROftW. The Asia-Pacific perspective: redefining obesity and its treatment. Sydney; 2000."},{"issue":"10","key":"10.1016\/j.ahj.2025.07.005_bib0028","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1038\/sj.ijo.0801739","article-title":"Relationships between indices of obesity and its co-morbidities in multi-ethnic Singapore","volume":"25","author":"Deurenberg-Yap","year":"2001","journal-title":"Int J Obes Relat Metab Disord"},{"issue":"11","key":"10.1016\/j.ahj.2025.07.005_bib0029","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1038\/sj.ijo.0801043","article-title":"Prediction of hypertension, diabetes, dyslipidaemia or albuminuria using simple anthropometric indexes in Hong Kong Chinese","volume":"23","author":"Ko","year":"1999","journal-title":"Int J Obes Relat Metab Disord"}],"container-title":["American Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870325002145?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870325002145?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T15:04:51Z","timestamp":1778943891000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002870325002145"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":29,"alternative-id":["S0002870325002145"],"URL":"https:\/\/doi.org\/10.1016\/j.ahj.2025.07.005","relation":{},"ISSN":["0002-8703"],"issn-type":[{"value":"0002-8703","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The impact of body mass index on antiplatelet monotherapy strategy for secondary prevention after percutaneous coronary intervention: A substudy of the HOST-EXAM trial","name":"articletitle","label":"Article Title"},{"value":"American Heart Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ahj.2025.07.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}